Literature DB >> 2297489

The chemotherapeutic response of a murine (VM) model of human glioma.

R Bradford1, J L Darling, D G Thomas.   

Abstract

Using a cell line derived from the VM spontaneous murine astrocytoma, a reliable in vitro-in vivo model of human malignant glioma has been developed. In this paper we examine the effects of cytotoxic drugs with known activity against other animal brain tumour models and human disease on the in vivo VM model. The drugs BCNU, CCNU and vincristine produced significant volume reduction in tumours growing at a subcutaneous location in syngeneic animals. Procarbazine was ineffective. Similarly, BCNU, CCNU and vincristine produced small but statistically significant increases in survival of VM mice bearing the intracerebral tumour, but procarbazine was again ineffective. The modest, but significant, response of the VM model to the nitrosoureas mimics the human situation more closely than previously described animal models.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297489      PMCID: PMC1971323          DOI: 10.1038/bjc.1990.10

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  USE OF MOVING AVERAGES AND INTERPOLATION TO ESTIMATE MEDIAN-EFFECTIVE DOSE: I. Fundamental Formulas, Estimation of Error, and Relation to Other Methods.

Authors:  W R Thompson
Journal:  Bacteriol Rev       Date:  1947-06

2.  A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs.

Authors:  R I Geran; G F Congleton; L E Dudeck; B J Abbott; J L Gargus
Journal:  Cancer Chemother Rep 2       Date:  1974-12

3.  Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.

Authors:  W R Shapiro; J I Ausman; D P Rall
Journal:  Cancer Res       Date:  1970-09       Impact factor: 12.701

4.  Heterogeneity of a cultured neoplastic glial line. Establishment and characterisation of six clones.

Authors:  H Koppel; J M Martin; G J Pilkington; P L Lantos
Journal:  J Neurol Sci       Date:  1986-12       Impact factor: 3.181

5.  Cell lines (VMDk) derived from a spontaneous murine astrocytoma. Morphological and immunocytochemical characterization.

Authors:  G J Pilkington; J L Darling; P L Lantos; D G Thomas
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

6.  Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.

Authors:  S C Schold; C E Rawlings; S H Bigner; D D Bigner
Journal:  Neurosurgery       Date:  1983-06       Impact factor: 4.654

7.  Improved treatment of a brain-tumor model. Part 1: Advantages of single- over multiple-dose BCNU schedules.

Authors:  M L Rosenblum; M A Gerosa; D V Dougherty; C B Wilson
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

8.  Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.

Authors:  S B Green; D P Byar; M D Walker; D A Pistenmaa; E Alexander; U Batzdorf; W H Brooks; W E Hunt; J Mealey; G L Odom; P Paoletti; J Ransohoff; J T Robertson; R G Selker; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  Cancer Treat Rep       Date:  1983-02

9.  The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.

Authors:  H M Warenius; L S Freedman; N M Bleehen
Journal:  Br J Cancer Suppl       Date:  1980-04

10.  High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

Authors:  E K Mbidde; P J Selby; T J Perren; D P Dearnaley; A Whitton; S Ashley; P Workman; H J Bloom; T J McElwain
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

View more
  4 in total

1.  The VM model of glioma: preparation of multicellular tumour spheroids (MTS) and their response to chemotherapy.

Authors:  R Bradford; J L Darling; N Sier; D G Thomas
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

2.  Heterogeneity of chemosensitivity in six clonal cell lines derived from a spontaneous murine astrocytoma and its relationship to genotypic and phenotypic characteristics.

Authors:  R Bradford; H Koppel; G J Pilkington; D G Thomas; J L Darling
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

Review 3.  What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.

Authors:  S Amarasingh; M R Macleod; I R Whittle
Journal:  J Neurooncol       Date:  2008-09-24       Impact factor: 4.130

4.  Interstitial infusion of carmustine in the rat brain stem with systemic administration of O6-benzylguanine.

Authors:  Mark M Souweidane; Giuseppe Occhiogrosso; Erika B Mark; Mark A Edgar; Ira J Dunkel
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.